TLX101-CDx (Pixclara) Granted FDA Fast Track Designation

Melbourne (Australia) | 16 April 2024 -- Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation1 for the Company’s investigational glioma imaging product, TLX101-CDx...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials